Literature DB >> 32104253

Th2 cells as an intermediate for the differentiation of naïve T cells into Th9 cells, associated with the Smad3/Smad4 and IRF4 pathway.

Mohamed Hamed Abdelaziz1, Huixuan Wang1, Jianjun Cheng1,2, Huaxi Xu1.   

Abstract

Type 9 T-helper (Th9) cells are associated with atopic and inflammatory diseases. Their increased levels and functions contribute to a number of inflammatory disorders, where they are accompanied by enhanced Th2-cell activity. However, there is currently no consensus regarding the association between Th9 and Th2 cells. Th9 cells may be induced from naïve T (Th0) cells under specific polarization conditions in vitro, a process driven by the addition of specific cytokines. In the present study, Th0 cells were cultured under Th9-polarizing conditions to promote differentiation into interleukin (IL)-4+ IL-9- or IL-4- IL-9+ T cells after 3 or 5 days in culture, respectively; the mRNA expression levels of IL-9 and IL-4 were consistent with the induced cell types. Simultaneously, the levels of interferon-regulatory factor 4 (IRF-4) and Smad3/Smad4 were significantly increased following Th9-cell polarization. It was therefore proposed that Th2 cells may be generated in the early stages of Th9-cell differentiation, and then ultimately differentiate into Th9 cells via the Smad3/Smad4 and IRF-4 activation pathway.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  Smad3; Th2 cells; Th9 cells; interferon-regulatory factor 4

Year:  2020        PMID: 32104253      PMCID: PMC7027129          DOI: 10.3892/etm.2020.8420

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  30 in total

1.  Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells.

Authors:  Guangpu Shi; Catherine A Cox; Barbara P Vistica; Cuiyan Tan; Eric F Wawrousek; Igal Gery
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 2.  IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation.

Authors:  Wei Liao; Jian-Xin Lin; Warren J Leonard
Journal:  Curr Opin Immunol       Date:  2011-08-31       Impact factor: 7.486

3.  IL-9 production of naive CD4+ T cells depends on IL-2, is synergistically enhanced by a combination of TGF-beta and IL-4, and is inhibited by IFN-gamma.

Authors:  E Schmitt; T Germann; S Goedert; P Hoehn; C Huels; S Koelsch; R Kühn; W Müller; N Palm; E Rüde
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

4.  Interleukin-21 suppresses the differentiation and functions of T helper 2 cells.

Authors:  Pin-Yi Lin; Hsiao-Yu Jen; Bor-Luen Chiang; Fuu Sheu; Ya-Hui Chuang
Journal:  Immunology       Date:  2015-04       Impact factor: 7.397

5.  Mutant p53 promotes tumor cell malignancy by both positive and negative regulation of the transforming growth factor β (TGF-β) pathway.

Authors:  Lei Ji; Jinjin Xu; Jian Liu; Ali Amjad; Kun Zhang; Qingwu Liu; Lei Zhou; Jianru Xiao; Xiaotao Li
Journal:  J Biol Chem       Date:  2015-03-12       Impact factor: 5.157

6.  Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset.

Authors:  Marc Veldhoen; Catherine Uyttenhove; Jacques van Snick; Helena Helmby; Astrid Westendorf; Jan Buer; Bruno Martin; Christoph Wilhelm; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2008-10-19       Impact factor: 25.606

7.  IFN-γ limits Th9-mediated autoimmune inflammation through dendritic cell modulation of IL-27.

Authors:  Gopal Murugaiyan; Vanessa Beynon; Andre Pires Da Cunha; Nicole Joller; Howard L Weiner
Journal:  J Immunol       Date:  2012-11-02       Impact factor: 5.422

8.  Activity of Group 2 Innate Lymphoid Cells is Associated with Chronic Inflammation and Dysregulated Metabolic Homoeostasis in Type 2 Diabetic Nephropathy.

Authors:  P Lu; X Ji; J Wan; H Xu
Journal:  Scand J Immunol       Date:  2018-01-03       Impact factor: 3.487

9.  The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation.

Authors:  Hua-Chen Chang; Sarita Sehra; Ritobrata Goswami; Weiguo Yao; Qing Yu; Gretta L Stritesky; Rukhsana Jabeen; Carl McKinley; Ayele-Nati Ahyi; Ling Han; Evelyn T Nguyen; Michael J Robertson; Narayanan B Perumal; Robert S Tepper; Stephen L Nutt; Mark H Kaplan
Journal:  Nat Immunol       Date:  2010-05-02       Impact factor: 25.606

10.  IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells.

Authors:  Valérie Dardalhon; Amit Awasthi; Hyoung Kwon; George Galileos; Wenda Gao; Raymond A Sobel; Meike Mitsdoerffer; Terry B Strom; Wassim Elyaman; I-Cheng Ho; Samia Khoury; Mohamed Oukka; Vijay K Kuchroo
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

View more
  1 in total

1.  Irradiated whole-cell vaccine suppresses hepatocellular carcinoma growth in mice via Th9 cells.

Authors:  Junying Chen; Yuxiong Ding; Fei Huang; Ruilong Lan; Zeng Wang; Weikang Huang; Ruiqing Chen; Bing Wu; Lengxi Fu; Yunhua Yang; Jun Liu; Jinsheng Hong; Weijian Zhang; Lurong Zhang
Journal:  Oncol Lett       Date:  2021-03-22       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.